OmniGuide, Inc., a commercial stage medical device company formally launches its Clinical Education program. The minimally invasive gynecologic surgery course consisted of lectures and laboratory sessions addressing both laparoscopic and robotic techniques.
Online PR News – 01-July-2013 – Cambridge, Mass – Cambridge, MA - OmniGuide, Inc., a commercial stage medical device company officially launched its Clinical Education program this past weekend at the Nicholson Center in Celebration, Florida. The course consisted of didactic lectures and hands on laboratory sessions, utilizing the OmniGuide advanced surgical energy system in both laparoscopic and robotically assisted gynecology techniques. Twelve gynecologic surgeons from across the United States attended the course conducted by three faculty surgeons.
“This is a great opportunity for gynecology practitioners to experience the innovative OmniGuide technology in a hands-on lab setting and share clinical experiences with other surgeons,” said Course Director, Antonio Gargiulo, MD. “To fully appreciate an advanced surgical device like the OmniGuide system, there is no better learning setting than a lab-based course.”
OmniGuide advanced surgical energy systems combine the surgical value of CO2 lasers with unprecedented precision, control, and access. The OmniGuide system delivers CO2 laser energy through novel flexible fibers, with the potential to improve patient outcomes as a result of enhanced precision and less damage to tissue around the surgical site.
Scott Flora, President and Chief Executive Officer of OmniGuide Surgical summed up the day by saying, “Innovative medical device companies have an ethical commitment to ensure we are training surgeons on the proper use of disruptive technologies such as our system. I’m proud of how our company has worked to engage the medical community and partner with leading surgeons to deliver a best in class educational program like the course here today.”
OmniGuide, Inc. is a leader in the development and marketing of advanced surgical energy solutions that improve precision, access and control. OmniGuide’s products are sold under the BeamPath® brand and are clinically targeted for superior clinical outcomes in Gynecology and ENT. The Company distributes its products in the U.S. through a direct sales force. OmniGuide is committed to developing products that improve and expand surgical treatment options, enhance clinical outcomes, and reduce treatment complexity and cost.
Additional information about OmniGuide may be found at www.omni-guide.com.
Brad Smith, CFO